Prodromal Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Prodromal Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Combined tDCS and Cognitive Training in Alzheimer's [NA]
Study results for combined transcranial direct current stimulation (tDCS) and cognitive training in prodromal Alzheimer's disease have been …
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Financial Incentives and Recruitment to the APT Webstudy [NA]
This entry reports a USC-sponsored clinical trial update on using financial incentives to recruit participants to the APT Webstudy for Alzhe…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Combined tDCS and Cognitive Training in Alzheimer's [NA]
A clinical trial evaluating the combination of transcranial direct current stimulation (tDCS) and cognitive training for prodromal Alzheimer…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease [NA]
A clinical trial update indicates recruitment is ongoing for a partnered rhythmic rehabilitation study in prodromal Alzheimer's disease.
-
CLINICAL_TRIALS other · 2024-06-14Clinical Trial Update: Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Clinical trial update on amyloid prediction in early-stage Alzheimer's disease through speech phenotyping (FUTURE Extension) indicates the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) [Phase 3]
Phase 3 trial of verubecestat (MK-8931) in prodromal Alzheimer's disease and amnestic MCI was terminated with posted results.